Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CAMBRIDGE NUTRITIONAL SCIENCES PLC Director's Dealing 2014

Nov 28, 2014

7544_dirs_2014-11-28_191e5d5c-a590-4c32-b521-1b48aa06db29.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2327Y

Omega Diagnostics Group PLC

28 November 2014

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director's Dealing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that David Evans, Non-Executive Chairman of the Company, purchased 173,500 ordinary shares in the Company at 15p per share on 27 November 2014.

Following this transaction, Mr Evans' total beneficial holding has increased to 3,043,634 ordinary shares representing 2.8 per cent of the issued ordinary share capital of the Company.

Contacts: 

Omega Diagnostics Group PLC Tel: 01259 763 030 or www.omegadiagnostics.com
Andrew Shepherd, Chief Executive
Kieron Harbinson, Group Finance Director   

Jag Grewal, Group Sales and Marketing Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash/Christopher Raggett (Corporate Finance)

Mia Gardner (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSPGGMPGUPCGQM